Koyfin Home > Directory > Health Care > Horizon Therapeutics > Return on Capital %

Horizon Therapeutics Return on Capital % Chart (HZNP)

Horizon Therapeutics annual/quarterly Return on Capital % from 2010 to 2020.
  • Horizon Therapeutics Return on Capital % for the quarter ending September 09, 2020 was 13.55 a 69.10% increase of 9.36 year over year
  • Horizon Therapeutics Return on Capital % for the last 12 months ending September 09, 2020 was 4.91 a 47.07% increase of 2.31 year over year
  • Horizon Therapeutics Annual Return on Capital % for 2019 was 2.60 a 48.49% increase of 1.26 from 2018
  • Horizon Therapeutics Annual Return on Capital % for 2018 was 1.34 a 160.81% increase of 2.15 from 2017
  • Horizon Therapeutics Annual Return on Capital % for 2017 was -0.81 a 88.59% decrease of -0.72 from 2016
Other Margins & Efficiency Metrics:
  • Horizon Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $15m a 306.02% increase of 47m year over year
  • Horizon Therapeutics Return on Equity % for the quarter ending December 12, 2018 was 35.54 a 291.21% increase of 103.49 year over year
View Chart On Koyfin

Quarterly HZNP Return on Capital % Data

09/202013.55
06/20202.64
03/2020-1.15
12/20194.19
09/20194.14
06/20192.97
03/2019-0.14
12/20185.32
09/20184.78
06/20181.35

Annual HZNP Return on Capital % Data

20192.60
20181.34
2017-0.81
2016-0.09
20152.58
20140.34
2013-24.75
2012-44.79
2011-34.10
2010-40.97